Increased prevalence of osteonecrosis of the femoral head in children and adolescents with sickle‐cell disease
Open Access
- 14 June 2011
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 86 (9) , 806-808
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)Blood, 2010
- The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐upAmerican Journal of Hematology, 2010
- Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension studyBlood, 2005
- Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experienceBlood, 2005
- Enalapril and hydroxyurea therapy for children with sickle nephropathyPediatric Blood & Cancer, 2005
- Avascular Necrosis of the Hip in Children with Sickle Cell Disease and High Hb F: Magnetic Resonance Imaging Findings and Influence of α-Thalassemia TraitActa Haematologica, 2001
- Morbidity, βs Haplotype and α-Globin Gene Patterns among Sickle Cell Anemia Patients in KuwaitActa Haematologica, 1996
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- Sickle Cell Disease as a Cause of Osteonecrosis of the Femoral HeadNew England Journal of Medicine, 1991
- Two different forms of homozygous sickle cell disease occur in Saudi ArabiaBritish Journal of Haematology, 1991